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Opiate addiction is now a major public health problem. Perinatal insults and exposure
to opiates such as morphine in utero are well known to affect development of the
hypothalamic–pituitary–adrenal axis of the offspring adversely and are associated with a
higher risk of developing neurobehavioral problems. Oxycodone is now one of the most
frequently abused pain killers during pregnancy; however, limited data are available
regarding whether and how perinatal oxycodone exposure (POE) alters neurobehavioral outcomes of the offspring. We demonstrated that exposure to 0.5 mg/kg/day
oxycodone in utero was associated with hyperactivity in adult rats in an open field. No
significant effects of POE were detected on isolation-induced ultrasonic vocalizations
in the early postnatal period or on learning and memory in the water maze in adult
offspring. Our findings are consistent with hyperactivity problems identified in children
exposed to opiates in utero.
Keywords: prenatal opiate exposure, prenatal oxycodone exposure, behavior, hyperactivity, ultrasonic
vocalization, learning and memory

INTRODUCTION
The prevalence of opiates and prescription opioid abuse among pregnant women is a major public
health concern. Non-prescription opioids are the second most abused illicit substance and one of the
most commonly abused opiate pain relievers is oxycodone (1). In 2015, an estimated 10.4% of the
population over 12 years of age used oxycodone products. Importantly, substance use in pregnant
women and subsequent fetal exposure to drugs have been linked to adverse health effects for the
maternal–fetal dyad. Opiates can affect the developing fetus directly or indirectly through various
mechanisms. Opiates can cross the placenta (2–4) and act directly on fetal opioid receptors. Opiates
can also enhance maternal secretion of cortisol in the mother or stimulate the secretion of stress
hormones in the fetus (5), which can pose long-term effects to the developing fetus (6) and the
hypothalamic–pituitary–adrenal (HPA) axis of the offspring (7, 8). In addition, because the HPA
axis has important roles in programming neurobehavioral development (9) and dysregulation of
the HPA axis has been linked to several neuropsychiatric disorders, such as anxiety (10), depression
(11, 12), ADHD (13), and learning/memory deficits (14, 15, 16), any opioid-induced changes in the
HPA-axis may also be associated with short- and long-term behavioral problems.
Both human and animal studies have shown that exposure to opiates has deleterious effects on
neurodevelopmental outcomes. However, most of them used other opiates, including morphine
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and heroin, which are mu-opioid receptor agonists, rather than
oxycodone, a semisynthetic putative kappa opioid receptor
(KOR) and partial mu opioid receptor agonist. Because illegal
oxycodone use during pregnancy continue to rise, and the effects
of opiates on the HPA axis differ depending on the type of opiate
(17, 18, 19), it is important to determine the effects of perinatal
oxycodone exposure (POE) on the neurobehavioral outcome of
the offspring.
The current study was designed to examine the potential
effects of POE on three diverse behaviors; isolation induced
ultrasonic vocalizations (USVs) in neonatal pups followed by
activity levels in adolescent rats and spatial learning in young
adult rats. Isolation-induced USVs are the responses of young
rat pups when separated from their mothers (20, 21). USVs are
considered an adaptive response of the pup and these USVs
correlate directly with distress and/or anxiety in the rat pup
(22). USVs elicit maternal behavior and play an important role
in the interaction between the pup and the dam (21). USV cues
may be comparable to the crying sounds of human infants (23),
which have been used to identify infants at risk for poor neurobehavioral outcomes (23, 24). Although existing data on the
effects of prenatal opiate exposure on isolation-induced USVs
remain limited, neonatal exposure to alcohol (25) or other illicit
drugs, such as cocaine, can alter many USV characteristics (26).
Therefore, we hypothesized that rat pups prenatally exposed to
oxycodone would have an increased latency to the first USV and
decreased USV numbers per minute.
The second testing paradigm used was an open field test,
which has been widely used to study hyperactivity, anxiety, and
stress in animals (27, 28, 29, 30). Although prenatal exposure to
morphine was not associated with increased locomotor activity
in the open field in rats (31, 32), human studies have shown
that children exposed to opiates in utero manifest hyperactivity,
impulsivity, and attention problems, whether the mothers were
in opiate maintenance therapy or were polysubstance users
(33, 34). Therefore, we hypothesized that POE would be associated with hyperactivity in the open field in rat offspring.
Learning and memory were assessed in a water maze.
Children prenatally exposed to opiates have learning problems
and lower scores on neurodevelopmental tests (35, 36, 37). In
rats, prenatal exposure to morphine is associated with learning
and memory deficits (38, 39). Thus, we hypothesized that POE
would impair learning and memory of the offspring. To the best
of our knowledge, these studies are the first to look at the effects
of POE on these behavioral measures.

Once released from quarantine, the females were fitted with a
right atrial cannula connected to a subcutaneous (S.C.) access port
implanted between the shoulder blades. The rats were allowed to
recover for 1 week. To determine estrous cycles, vaginal lavages
were obtained daily. Each female was group housed with a proven
breeder male for breeding 1 week after cannulation. Gestational
day (GD) 0 was designated as the day that sperms were detected
in the vaginal smear, and the females were individually housed
thereafter. Foster dams were bred at the same time and remained
untreated throughout their gestation.
The cannulae were flushed daily via the S.C. port with sterile
heparinized saline (0.4 cc, 100 IU/ml) until GD 8. From GD 8–21,
the experimental dams were divided into three treatment groups
that received either oxycodone (Mallinckrodt, St. Louis, MO,
USA) at a low (OXY-L, 0.5 mg/kg/day, n = 5) or high dose (OXYH, 2.0 mg/kg/day, n = 12) or an equivalent volume of vehicle
[control (CON), normal saline solution (NSS, 1.0 ml/kg/day),
n = 12] from GD 8–21. These solutions were slowly injected i.v.
over 10 min via the S.C. access port manually.
On postnatal day (PD) 1, the pups were counted and weighed.
Oxycodone or NSS was also administered on PD 1, 3, and 5 to
the dams because brain development during early postnatal life
overlaps the human “third trimester” brain growth spurt and
to prevent maternal withdrawal symptoms that might affect
maternal nursing behavior. On PD 2 all litters were adjusted to
contain 10–11 pups with equal numbers of male and female pups
when possible. At 1700 h on PD 5, all pups in each litter were
transferred to an untreated foster dam to minimize exposure
to altered maternal rearing behavior that has been described in
rat dams after exposure to opiates (40). To preclude potential
litter effects, only one male and one female from each litter were
included in the behavioral studies (41). The pups were weighed
daily and weaned at PD 25, when they were separated by sex.

Experimental Design: Behavioral Tests
Ultrasonic Vocalizations

Ultrasonic Vocalizations were determined according to published
procedures (42). In brief, an ultrasonic bat detector (Ultra Sound
Advice Model #S-25, UK—http://www.ultrasoundadvice.co.uk)
set at 40 kHz with a condenser microphone (SM-1) set 21.5 cm
above the test cage floor was used. The output was recorded on
a SONY #WM-D8C Cassette Recorder using low noise cassette
tapes. On PD 14, the pups in each litter were separated from
the dams, remaining in their home cage and were brought to a
neighboring test room one litter at a time. Their cages were placed
halfway on a heating pad to provide warmth. During testing,
the dam was placed in a new cage in the same test room. CON
offspring (n = 6) and OXY-L (n = 4) and OXY-H (n = 8) rats
underwent USV testing. The number of pups in the OXY-L group
was smaller due to smaller numbers of dams in this group and
limited numbers of pups available for all experiments that were
performed. During USV testing, pups were isolated one at a time
in a clean cage for 6 min during which USVs from the pup were
recorded. A fan was used to provide white noise during testing.
Upon completion of USV testing for the entire litter, the dam was
returned to the home cage and the home cage was returned to
their original animal room.

MATERIALS AND METHODS
Experimental Design: Animals
and Prenatal Treatments

The study protocol was approved by the University of Kentucky
Institutional Animal Care and Use Committee. Virgin female
Sprague Dawley rats (Harlan, Indianapolis, IN, USA) weighing
194–223 g were individually housed at 22–25°C and maintained in
a 14L:10D photoperiod (lights on at 0500 h) room with regulated
30–70% humidity. Rat chow and water were provided ad libitum.

Frontiers in Pediatrics | www.frontiersin.org
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Assessment of USV: audio data for each 6-min test period
were individually scored for latency to vocalization (seconds)
and number of USVs per minute per test period. Scoring was
performed independently by two experimenters who were blind
to the treatment groups and used a stopwatch and clicker counter.
Similarity of their scores was compared and indicated that the
reliability between experimenters was greater than 90%.

recorded using a video tracking system (SMART program;
Panlab, S.L.) (43).
On the first trial, the rat was placed in the maze and allowed to
swim freely. If the animal did not reach the platform after 1 min, it
was guided to the platform. After 5 s on the platform, the animal
was transferred to a cage warmed by a heat lamp (25 W) for 30 s.
Trials were repeated until the animal completed two consecutive
trials without errors (wrong turns) or a total of three successful
trials. The number of trials required to reach either criterion was
recorded as the outcome measure. The next day the rats were
tested identically for 24 h to determine retention.

Open Field Test

On PD 43, a group of offspring that had not undergone USV testing were transferred to another building, where they were housed
for at least 7 days prior to subsequent behavioral testing. This was
an independent group of subjects, i.e., not the same offspring that
had previous USV testing. The open field test was preceded by
5 days of habituation to the new surroundings followed by 2 days
of 3-min handling periods and weighing. CON offspring (n = 30,
19 males, 11 females) and OXY-L (n = 8, 4 males, 4 females) and
OXY-H (n = 32, 17 males, 15 females) rats underwent open field
tests on PD 50–51. The number of pups in the OXY-L group was
smaller due to limited numbers available after other experiments
(not described herein) were performed. The open field apparatus was a circular chamber 36 cm height and 58 cm diameter.
This circular chamber was used to prevent thigmotaxis or excessive time in corners (43). In addition, the open field was divided
into two zones, with the center zone representing 25% of the total
area. All testing was conducted in a test room with white noise to
reduce external distractions. On days 1 and 2 of testing, two rats
were transferred in separate cages and brought into the test room
for a 10 min habituation period. Each animal was then placed in
a separate open field, and their activities were recorded with a
Polytracker® (San Diego Instruments, San Diego, CA, USA) for
30 min. The animals were then returned to their home cages in
the colony room upon completion of testing.
Activity was recorded in 5 min blocks across the 30 min test
period for each day. Total distance traveled (cm), distance traveled in the center zone, and the ratio of distance traveled in the
center zone to total distance traveled or to distance in the outer
zone were determined.

Statistical Analyses

Statistical analyses were considered significant if p < 0.05.
Multilevel linear regression models or linear mixed effects models were used to analyze USVs, open field and water maze data.
Such models accounted for potential litter effects and correlation
among outcomes from the same pup over time. The models were
fitted using restricted maximum likelihood to test for the impact
of treatment group, gender, time, and any potential interactions
these variables have on the mean values for the data. Due to
skewness and outliers of the data, a natural log transformation
was applied when appropriate. The Kenward and Roger (45)
approximation was used to estimate standard error and degrees
of freedom. Variables (trial days, sex, and treatment groups)
were treated as categorical and backward elimination at the 5%
significance level was utilized. Kruskal–Wallis tests were applied
to compare litter sizes and number of males per litter between
treatment groups. A linear mixed-effects model was applied to
compare differences in body weight between groups with treatment group, gender, PD, and the interaction of gender and PD
included as predictors of weight. Tests were two-sided and were
conducted in SAS version 9.4 (SAS Institute, Cary, NC, USA).

RESULTS
Litter Size and Body Weight

Perinatal oxycodone exposure did not affect litter size or number
of males and females per litter (Table 1).
Although the average maternal weight gain during pregnancy
was different between groups (p = 0.005), perinatal oxycodone
treatment did not affect mean birth weight of male or female pups
weighed within 24 h after birth (Table 1). Dams in the OXY-H
group gained less weight than CON dams (p = 0.01) and OXY-L
dams (p = 0.023) (Table 1). Oxycodone treatment did not affect
weight gain of the pups; body weights up to PD 50 were not different between groups (p = 0.61). However, there was an interaction between gender and postnatal age (p < 0.0001); males and
females had different growth trajectories over time, as expected
(Figure 1).
Body weights of both male and females were similar across
treatment groups in the rats tested in the open field and water
maze (p = 0.43), the females weighing less than the males as
expected (p < 0.0001) (Table 1). The body weight of the pups
at the time of USV testing (PD14) (g ± SEM) were 30.9 ± 1.8 in
male and 29.1 ± 1.6 in female CON group; 30.2 ± 1.9 in male and

Water Maze

On PD 55–56, two groups of offspring, CON (n = 20, 11 males, 9
females) and OXY-H (n = 20, 10 males, 10 females) were tested
in the water maze. Rats from the OXY-L group were not tested
due to the limited numbers of pups. This experiment was modified from a procedure previously described (43). The apparatus
was a 130 cm × 90 cm × 40 cm black Plexiglas chamber, divided
such that several divergent paths, each 18 cm wide, branched
off from the central start area. The apparatus and methodology
were modified from von Euler et al. (44). Water temperature
was maintained at 76° ± 2°. In this test, rats must learn to swim
and make three successive right/left choices to a platform that
is submerged below the water level and invisible; the water was
made black with the addition of non-toxic black tempera paint
to obscure the submerged platform. A plastic sheet surrounded
the maze, reducing extra-maze cues, including the experimenter.
A major advantage of this maze is that control animals can
learn the maze in a single day. Movement in the maze was

Frontiers in Pediatrics | www.frontiersin.org
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TABLE 1 | Litter size, the number of male and female rat pups per litter, maternal weight gain during pregnancy and birth weight of the pups and weight of the young
adult offspring at the neurobehavioral tests (g ± SEM).
Variable (number of litter)

CON (N = 11)

OXY-H (N = 13)

OXY-L (N = 5)

Total number of pups per litter
Number of females per litter
Number of males per litter
Maternal weight gain during pregnancy, mean ± SEM (g)

13.3 (14) ± 2.9
5.9 (6) ± 2.1
7.4 (8) ± 3.0
153 ± 7.3*

12.3 (13) ± 4.4
6.5 (7) ± 3.1
5.8 (6) ± 2.5
113.4 ± 10.0*#

14.4 (14) ± 1.5
6.0 (6) ± 1.0
8.4 (8) ± 0.5
156.1 ± 9.0#

p-Value
n.s.
n.s.
n.s.
*p = 0.01, CON vs OXY-H, diff 39.7 g
p = 0.023, OXY-H vs OXY-L, diff 42.8 g

#

Birth weight, mean ± SEM (g)
Male (M)
Female (F)
Body weight during neurobehavioral tests (adult)

M:6.4 ± 0.2
F: 6.0 ± 0.2
M: 223 ± 6.7
F: 169 ± 5.4

M: 6.2 ± 0.3
F: 5.8 ± 0.3
M: 250 ± 1.5
F: 177 ± 3.5

M: 6.1 ± 0.4
F: 5.6 ± 0.5
M: 210 ± 8.0
F: 175 ± 4.9

n.s.
n.s.
n.s.

CON, control; OXY-H, oxycodone high dose; OXY-L, oxycodone low dose.

FIGURE 1 | Body weight of male and female offspring: left panel: body weight of male pups from birth through postnatal day (PD) 50 in control (CON, closed circles,
n = 81), oxycodone low dose (OXY-L, open circles, n = 42) and oxycodone high dose (OXY-H, closed triangles, n = 76) groups. Right panel: body weight of female
pups from birth through PD 50 in control (CON, closed circles, n = 65), OXY-L (open circles, n = 30) and OXY-H (closed triangles, n = 84) groups.

Open Field Test

28.1 ± 1.9 in female OXY-L group; and 30.1 ± 1.4 in male and
28.7 ± 1.1 in female OXY-H group.

Analysis of Total Distance Traveled in 30 Min

Analysis of the raw data indicated that there were no statistically
significant differences in total distance traveled among rats in
CON, OXY-L, or OXY-H groups (p = 0.26). There was also no
effect of test day on the total distance traveled (p = 0.48). No
interactions were significant. Female rats traveled a greater total
distance compared to males [traveled 1,654 cm further than
males, 95% CI: (539, 2,768), p = 0.004]. After a natural log transformation of the data, because of outliers and skewness, it was
similarly determined that females traveled a greater total distance
than males (p < 0.0001). In addition, this transformation of the
data revealed that the OXY-L rats traveled farther than rats in
both other treatment groups (vs OXY-H, p = 0.011; vs CON,
p = 0.0004, Figure 3). This difference was likely largely driven by
OXY-L-treated males on day 2.
There was no main effect of perinatal treatment or test day
(p = 0.10 and p = 0.07, respectively) on the total distance per
5 min block. However, females travel 241 cm further than males
in any given 5 min period (p = 0.003). The mean total per 5 min
time block decreased over time (p < 0.0001), Figure 3.

Ultrasonic Vocalizations

There were no significant sex differences so results were collapsed
across sex for subsequent USV analyses. There was no significant
difference in the latency to the first vocalization between treatment groups; however, there was a trend for longer latencies in
OXY-exposed rats, Figure 2A. Latency to the first USV as plotted
in Kaplan–Meier Plots is shown in Figure 2B, a point on the
plot denotes the estimated probability of having a first USV after
the given time point. Although there was a trend for prenatal
oxycodone-exposed pups to display longer latencies to their first
USV after isolation, there were no significant differences between
treatment groups (p = 0.25), likely due to small sample sizes,
Figure 2B.
Total USVs across time also did not differ among the three
treatment groups (p = 0.85), Figure 2C. The number of USVs
increased across time in all treatment groups (p = 0.0004); however, there was no significant effect of perinatal OXY exposure
(p = 0.32), Figure 2D.
Frontiers in Pediatrics | www.frontiersin.org
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FIGURE 2 | (A) Latency to the first vocalization of rat pups; (B) Kaplan–Meier plot of latency to the first ultrasonic vocalizations (USVs) in rat pups in control (CON,
solid line), oxycodone low dose (OXY-L, long dashed line), and oxycodone high dose (OXY-H, dotted line) groups; (C) total number of vocalizations of rat pups
during USV test in CON (white bar; n = 6), OXY-L (gray bar; n = 4), and OXY-H (black bar; n = 8) groups; and (D) number of USVs per minute across the testing
period in CON (closed circles), OXY-L (open circles), and OXY-H (closed triangles) groups.

Analysis of Total Distance Traveled in the Inner Zone,
Outer Zone, and Mean Ratio of Distance Traveled in
the Inner/Outer Zone
The Inner Zone

There were no interactions in outer zone distance per 5 min
and no effect of oxycodone treatment (p = 0.15). Females travel
194 cm further than males in the outer zone in any given 5 min
period (p = 0.01), Figure 5. In addition, rats tended to travel
113 cm further on the first test day in any given 5 min time period
(p = 0.032), Figure 5. The mean total distance traveled in the
outer zone per 5 min period decreased over time as expected
(p < 0.0001), Figure 5.

Rats exposed to OXY-L traveled more in the inner zone than rats
in the other two treatment groups (OXY-L vs OXY-H, p = 0.011;
vs CON, p = 0.003), likely due to the travel of the OXY-L-treated
males on day 2, Figure 4. The distance traveled in the inner zone
did not differ between days (p = 0.61), and no interactions were
significant.
Oxycodone treatment did not affect the distance traveled in
the inner zone per 5 min block, Figure 4. The large standard
errors were likely due to the small sample size.

The Ratio of the Distance Traveled in the Inner Zone
to Outer Zone

The ratio of activity in the center zone vs outer zone of the
field is a potential marker of motor impulsivity and/or anxiety
(46). There were no differences in mean ratios across test days
(p = 0.18) but there was a treatment group × sex interaction
(p = 0.003; sex × treatment group interaction). Specifically,
the estimated mean ratio of the distance traveled in the inner
to outer zone of male OXY-L rats which was 0.245, was 0.095
larger than that of the CON, p = 0.008, and 0.112 larger than for
OXY-H, p = 0.002 (Table 2). This pattern differed across sex; no
differences in the inner:outer ratio were observed in the females
(estimated mean ± SEM for days 1 and 2 in CON: 0.13 ± 0.01,
OXY-L: 0.10 ± 0.05, and OXY-H: 0.17 ± 0.02) (Table 2). The
differences in the males persisted when the ratios of distance
traveled in the inner to outer zone for each 5 min time block were

Outer Zone

There were no significant interactions. Neither oxycodone
treatment nor testing day impacted the mean total outer zone
distance (p = 0.35 and p = 0.29, respectively), Figure 5. After
natural log transformation and removal of two outliers, there
were main effects of gender (p < 0.0001) and treatment group
(p = 0.005). Namely, males traveled to the outer zone less than
females (p = 0.003) and OXY-L rats traveled more in the outer
zone than the CON group (p = 0.002, Figure 5). There was no
difference in outer zone distance traveled between either CON or
OXY-L compared to OXY-H, Figure 5.
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FIGURE 3 | Total distance traveled in each 5 min time block in the open field on test day 1 (upper panel) and test day 2 (lower panel), by males (left panel) and
females (right panel) in control (CON, closed circles; male n = 19, female n = 11), oxycodone low dose (OXY-L, open circles; male n = 4, female n = 4), and
oxycodone high dose (OXY-H, closed triangles; male n = 17, female n = 15) groups.

Open Field Test

analyzed (OXY-L vs CON: p = 0.04; OXY-L vs OXY-H = 0.007),
Figure 6.

Oxycodone low dose rats were hyperactive and traveled more in
the inner zone of the open field compared to CON and OXY-H
rats, resulting in a higher mean ratio of inner:outer zone distance
traveled by the OXY-L males. Thus, perinatal exposure to oxycodone was associated with hyperactivity behavior in adolescence.
In addition, the increase in the ratio of inner zone:total distance
traveled suggests that perinatal oxycodone reduced anxiety-like
behavior and decreased normal species-typical thigmotaxic
behavior in a new environment. Alternatively, these differences
might reflect overall hyperactivity with a failure to inhibit entries
to the center. It remains to be determined whether the increased
travel in the center is due to deficits in hyperactivity, impulse
control, or reduction in anxiety.
Our finding that perinatal exposure to oxycodone was
associated with hyperactivity in the offspring is in agreement
with human studies that identify hyperactivity, impulsivity,
and attention problems in children exposed to opiates in utero
(33, 34). In animal models, however, the results are more conflicting due to differences in studied drugs, which were mainly
morphine, as well as in paradigms, ages, instruments, and end

Water Maze

Using a multivariate repeated measures Gaussian linear model
to analyze the data with trial days, treatment groups and sex as
predictor categories, there was no effect of oxycodone or sex on
the mean values of the average number of trials until criterion
performance was reached on both days (p = 0.62). The expected
decrease in the mean values of the average number of trials on day
2 was observed in all groups (p < 0.0001) (Figure 7).

DISCUSSION
We explored the effects of POE on behavioral outcomes using
three behavioral tests (USV, open field, and water maze) in juvenile, adolescent, and young adult rats. POE increased locomotion
and preference for the center in the open field, consistent with
hyperactivity. However, we did not find any effects of POE on
USVs of rat pups when separated from their mothers or on learning and memory in the water maze.
Frontiers in Pediatrics | www.frontiersin.org
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FIGURE 4 | Total distance traveled in inner zone in each 5 min time block in the open field on test day 1 (upper panel) and test day 2 (lower panel), in males (left
panel) and females (right panel) in control (CON, closed circles), oxycodone low dose (OXY-L, open circles), and oxycodone high dose (OXY-H, closed triangles)
groups.

points. For example, in one study, postnatal handling but not
prenatal morphine exposure increased locomotor activities in
the open field in adult male and female rats (31). In contrast,
others reported that postnatal stress but not prenatal exposure
to morphine increased locomotor activity in the open field
(32). Thus, morphine yields different results than oxycodone
in the open field. However, it should be noted that the effects
of morphine are contradictory among studies and differ among
tests. Thus, prenatal exposure to morphine was associated with
increased anxiety-like behavior in an elevated plus maze (EPM)
and reduction in time spent in the lit side of a light/dark box
(L/D box) (47). Others reported that rats prenatally exposed to
morphine exhibited decreased anxiety-like behavior in the EPM
and L/D box with no differences in distance traveled over 30 min
in the open field (48). Another study reported no significant
anxiogenic effect of prenatal morphine exposure determined in
the EPM (49). Finally, prenatal exposure to several opiates, such
as methadone, buprenorphine, and most effectively morphine,
increased anxiety-like behaviors in the light–dark transition test,
with no effect on locomotor activity in an open field (50).
A possible mechanism by which prenatal exposure to opiates
could result in hyperactivity may involve changes in multiple
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neurotransmitter signaling pathways such as dopaminergic
pathways and the HPA system. It is well described that opioids
have a significant role in controlling the release of dopamine and
acetylcholine in the key reward regions of the brain including
the ventral tegmental area (VTA) and the nucleus accumbens
(51, 52, 53, 54). Long-term exposure to opiates leads to both
structural and biochemical changes in the mesolimbic dopaminergic system; for example, a reduction in the cell size of
dopaminergic neurons in the VTA (55), and increased levels of
tyrosine hydroxylase, which is the rate-limiting enzyme in the
synthesis of dopamine in the VTA (56). In addition, convincing
evidence suggests that the impairment of dopamine-mediated
development and the monitoring of motivated behavior and
reward-related memory formation might be associated with
ADHD symptoms (57, 58). Thus, taken together, it is possible
that perinatal exposure to opiates may disrupt the normal
development of dopaminergic reward-related circuits leading to
hyperactive behavior. However, this speculation remains to be
further elucidated.
Changes in the HPA system have also been linked to ADHD
symptoms. In children, both reduced basal cortisol secretion and cortisol hyporeactivity have been associated with
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FIGURE 5 | Total distance traveled in outer zone in each 5 min time block in the open field on test day 1 (upper panel) and test day 2 (lower panel), by male (left
panel) and female (right panel) rats in control (CON, closed circles), oxycodone low dose (OXY-L, open circles), and oxycodone high dose (OXY-H, closed triangles)
groups.

TABLE 2 | The mean ratios of the distance traveled in the inner to outer zone in
male and female rats in 30 min testing period.
Test day

CON (SEM)

OXY-L (SEM)

OXY-H (SEM)

Male
1
2
Estimated mean day
1 and 2

0.13 (0.01)
0.15 (0.01)
0.14 (0.01)

0.19 (0.09)
0.27 (0.07)
0.24 (0.07)*

0.13 (0.01)
0.13 (0.01)
0.12 (0.01)

Female
1
2
Estimated mean day
1 and 2

0.13 (0.01)
0.14 (0.02)
0.13 (0.01)

0.10 (0.04)
0.11 (0.04)
0.10 (0.05)

0.17 (0.03)
0.17 (0.02)
0.17 (0.02)

*p < 0.05 {the estimated mean ratio of distance traveled in the inner to outer zone of
male OXY-L rats which was 0.245, was estimated to be 0.095 larger than that of the
CON [95% CI: (0.027, 0.162), p = 0.008], and 0.112 larger than for OXY-H [95% CI:
(0.042, 0.1830, p = 0.002)]}.
CON, control; OXY-H, oxycodone high dose; OXY-L, oxycodone low dose.

FIGURE 6 | The ratio of the distance traveled in the inner/outer zone in
30 min in the open field (mean ± SEM) by male (left panel) and female (right
panel) rats in control (CON, closed circles), oxycodone low dose (OXY-L,
open circles), and oxycodone high dose (OXY-H, closed triangles) groups.
Male OXY-L rats had overall higher ratios of distance traveled in the inner to
outer zone for each 5 min time block across time compared to other
treatment groups (OXY-L vs CON: p = 0.04; OXY-L vs OXY-H = 0.007).

hyperactivity/impulsivity or a combined type ADHD (59). An
abnormal diurnal rhythm and less effective negative feedback
mechanisms after a dexamethasone suppression test were
also identified more frequently in the children with ADHD
that were severely hyperactive compared to those with milder
symptoms (60). In agreement with many community-based
Frontiers in Pediatrics | www.frontiersin.org

studies, in which ADHD is more prevalent in males (61), in our
study hyperactivity was more notable in the male OXY-L group.
Interestingly, in adults with ADHD, although the basal salivary
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perinatal cocaine treatment decreased the number of USVs on
PD 1 and on PD 21, but this effect was not observed on PD 14
(66). Therefore, it is possible that the lack of an effect of oxycodone in our study occurred because testing was limited to PD
14. In fact, there are other types of USVs based on frequency
and duration that are elicited as the rat becomes more mature
(67). These include a 22 kHz USV emitted by juvenile and adult
rats in response to predators and pain indicating a negative
affective state (68, 69), and a 50 kHz USV emitted in adult rats
in response to rewarding stimuli, expressing a positive affective
state (70, 71). So it is also possible that POE may affect these
other types of USVs that were not tested at an older age.
FIGURE 7 | The mean number of trials in the water maze in male (left panel)
and female (right panel) rats in control (CON, white bars, n = 20, 11 males, 9
females) and oxycodone high dose (OXY-H, black bars, n = 20, 10 males, 10
females) group.

Water Maze

We did not find any effects of POE on spatial learning and/or
memory in the water maze test as hypothesized; this may have
resulted from not including rats perinatally exposed to a lower
dose of oxycodone in this experiment due to the small sample
size of this group. Previous studies using prenatal morphine
exposure models report conflicting results; memory and
learning in rodents are either impaired or enhanced. Namely,
juvenile rats prenatally exposed to morphine had impaired
spatial memory in the Morris water maze or Y-maze test (38,
72, 73), but aberrant memories such as morphine reward
memory in the conditioned place preference or forced swim
tests were enhanced (49, 74–76). In contrast to our study,
Davis et al. (39) found that prenatal exposure to oxycodone
impaired spatial learning and memory in a battery of spatial
tasks; in the Morris water maze, rats prenatally exposed to OXY
had increased latency and greater distance traveled to find the
platform when the intertrial interval was long, not short. Rats
prenatally exposed to oxycodone also had a decreased use of
spatial strategies and more use of non-spatial strategies such as
wall-hugging. In addition, the retention of learning memory
in the T-maze, assessed 5 days after acquisition of the training,
was impaired. This finding is actually consistent with our report
that although POE male rats were able to discriminate between
the stress and non-stress cues during a classical conditioning
paradigm on PD 40, they had impaired discrimination ability
when retested on PD 75 (77). Moreover, rats prenatally exposed
to oxycodone have more reference memory errors in the radial
arm maze (39). These differences in results could be due to
many reasons. In their study, the dose and route of administration of OXY were different than those used in the current
experiment with escalating doses of OXY (10 mg/kg/day up to
15 mg/kg/day) via gavage for 28 days prior to breeding. In addition, the pups were reared by their biological mothers in their
study, while surrogate fostering was used in the current study.
A number of previous studies have shown that opiate administration negatively alters maternal rearing behavior toward the pups
including measures such as cleaning of the pups, delay of maternal behaviors, and maternal aversion to pup odor (78, 79, 80).
Neonatal rearing condition and neonatal maternal interaction
such as maternal separation had long-term effects on the stress
response of the offspring including an increase in restraint stressinduced norepinephrine release in the PVN in adult rats (81) and
changes in the HPA axis at multiple levels that could be linked

cortisol levels were not different, cortisol levels 20-min after a
mental cognitive stress test were higher than those in healthy
adult controls (62). These findings are similar to our observations that POE is associated with increased CRH-induced
ACTH release (8) and with increased corticosterone reactivity
to restraint stress in adult female rats (unpublished). However,
we did not measure corticosterone, the major circulating glucocorticoid in rats, during the behavioral tests in the current
studies. The discrepancy between hyperactivity in males and
increased levels of corticosteroids in females could be due to
the methods used to produce the stress in each study, relatively
small sample sizes, and/or the gender of the participants.
Referral biases and methodological difficulties were present in
other human studies (63, 64). Thus, the relationship between
POE, hyperactive behaviors, and abnormal HPA axis function
that may interact with gender warrants further investigations,
which should include the measurement of corticosterone
during and after neurobehavioral testing. The abnormal HPA
axis response to stress may be a promising candidate for use
as a biomarker for early detection and treatment of ADHD in
infants prenatally exposed to oxycodone/opiates.
Data from both animal and human studies suggest that early
nutritional stress and malnourishment are associated with anxiety, high impulsivity, and attention problems (65). Although the
weight gain of the OXY-H dams was significantly lower than
that in the other groups, the weight gain of the OXY-L dams was
actually comparable to that in the CON group. In addition, birth
weights of the pups were comparable in all groups. Therefore,
the hyperactivity in the open field of the OXY-L group could not
solely be explained by poor maternal nutritional status.

Ultrasonic Vocalizations

Although there was a trend toward increased latency to first
vocalization, oxycodone treatment had no effect on this end
point or on the number of vocalizations per minute. The lack
of differences in these USVs parameters may be due in part
to the relatively low sample size in the OXY-L group. To our
knowledge, there are no reports thus far on the effects of perinatal oxycodone on USVs In contrast to our results, however,
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to epigenetic modification (82). Variations in maternal care
also influence learning and behaviors of the offspring (83, 84).
The adverse effects of neonatal maternal separation on the HPA
axis were lessened by fostering the litters (85). Thus, fostering
the pups when the dams were exposed to opiates could alter
the HPA axis and possibly the neurobehavioral outcomes of the
offspring. In addition, even though signs of withdrawal in the
dams were monitored in the study by Davis et al., body weights
of the OXY pups were approximately 10% lower than those of
the controls, indicating possible neonatal opiate withdrawal
and poorer nutritional status that can also affect long-term
outcomes. In contrast, the body weights of the pups in our study
were comparable in all groups.
In humans, prenatal exposure to opiates results in impairments
in cognitive function and learning. Bunikowski et al. also reported
that when evaluated at 1 year of age, children prenatally exposed
to opiates had a mild psychomotor developmental impairment
compared to the control group; these included impairments in
“hearing and speech” and “intellectual performance” subscales
(36). Guo et al. found that in utero opiate exposure was associated with impairments in the Auditory Rare Event Monitoring
task and the Sternberg Memory task in children 7–12 years of age
(35). More recently, Hunt et al. reported from their case–control
study that infants prenatally exposed to opiates are more likely
to experience neurodevelopmental impairments compared to
healthy control infants, when assessed at 18 months and 3 years
of age (37). The deleterious effects of prenatal opiate exposure on
cognitive function persisted and did not decrease over time after
controlling for permanent home placement and heroin use in the
mother when children prenatally exposed to opiates were retested
on the Wechsler Intelligence Scale for Children from 1 year old up
to 8.5 years of age (86). These data suggest that prenatal exposure to
opiates is associated with impaired cognitive functions. Therefore,
although we did not detect any effects of POE on cognitive function, learning, and memory using a water maze as a paradigm,
further investigation is warranted with different testing paradigms,
testing at different ages, and with a lower dose of oxycodone.
Interestingly, we found that exposure to the lower dose of
oxycodone of 0.5 mg/kg/day but not the higher dose of 2.0 mg/
kg/day was associated with hyperactivity in the offspring. This
difference could be due to the development of tolerance to the

higher dose of oxycodone. Opiate tolerance is characterized to
be pharmacodynamic, time and dose-dependent, and opioid
receptor specific (87). Tolerance can develop after exposure to
a KOR agonist (88) even for as short as 5 days (17). Whether
or not tolerance to the stimulatory effects on the HPA axis by
KOR agonists is dose-dependent has not been well studied, but
tolerance to MOR agonists was dose-related (89). It is possible
that in our study, rat dams that were exposed to the higher dose of
oxycodone (2 mg/kg/day) may have developed opioid tolerance
leading to a decreased fetal CORT exposure, thus there were fewer
effects on the developing HPA axis and the neurodevelopmental
outcomes of the offspring.
In summary, POE was associated with hyperactivity in young
adult rats. In these studies, perinatal oxycodone treatment had
no effect on the responses of pups isolated from their dams, or
in learning and memory deficits, which could be due to the small
sample sizes, testing paradigms, or the doses of oxycodone tested.
These issues remain to be resolved.
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